276 related articles for article (PubMed ID: 36900005)
1. Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.
Alfaifi A; Refai MY; Alsaadi M; Bahashwan S; Malhan H; Al-Kahiry W; Dammag E; Ageel A; Mahzary A; Albiheyri R; Almehdar H; Qadri I
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900005
[TBL] [Abstract][Full Text] [Related]
2. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma.
Smith MR
Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition.
Khan AE; Gallo V; Linseisen J; Kaaks R; Rohrmann S; Raaschou-Nielsen O; Tjønneland A; Johnsen HE; Overvad K; Bergmann MM; Boeing H; Benetou V; Psaltopoulou T; Trichopoulou A; Masala G; Mattiello A; Grioni S; Tumino R; Vermeulen RC; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Lund E; Ardanaz E; Chirlaque MD; Jakszyn P; Larrañaga N; Losada A; Becker N; Nieters A; Martínez-García C; Agren A; Hallmans G; Berglund G; Manjer J; Allen NE; Key TJ; Bingham S; Khaw KT; Slimani N; Ferrari P; Boffetta P; Norat T; Vineis P; Riboli E;
Haematologica; 2008 Jun; 93(6):842-50. PubMed ID: 18443270
[TBL] [Abstract][Full Text] [Related]
7. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
[TBL] [Abstract][Full Text] [Related]
8. Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma.
Norval EJ; Raubenheimer EJ
J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S90-5. PubMed ID: 25364188
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
10. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.
Esmeray E; Küçük C
Turk J Biol; 2020; 44(1):1-14. PubMed ID: 32123491
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
McCune RC; Syrbu SI; Vasef MA
Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
[TBL] [Abstract][Full Text] [Related]
14. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
Kim H; Nathwani BN; Rappaport H
Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
Ozbudak IH; Akkaya B; Karpuzoğlu G
Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869
[TBL] [Abstract][Full Text] [Related]
16. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.
Aslam W; Habib M; Aziz S
Cureus; 2022 Jun; 14(6):e25620. PubMed ID: 35784957
[TBL] [Abstract][Full Text] [Related]
18. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
19. [Primary non-Hodgkin lymphoma of the stomach. A review with special reference to the MALT concept].
Cogliatti SB; Schmid U
Schweiz Med Wochenschr; 1994 Oct; 124(40):1764-74. PubMed ID: 7939542
[TBL] [Abstract][Full Text] [Related]
20. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
